Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Conmed (CNMD) Net Margin (2016 - 2026)

Conmed filings provide 17 years of Net Margin readings, the most recent being 4.36% for Q1 2026.

  • On a quarterly basis, Net Margin rose 248.0% to 4.36% in Q1 2026 year-over-year; TTM through Mar 2026 was 4.0%, a 502.0% decrease, with the full-year FY2025 number at 3.42%, down 671.0% from a year prior.
  • Net Margin hit 4.36% in Q1 2026 for Conmed, down from 4.49% in the prior quarter.
  • In the past five years, Net Margin ranged from a high of 16.78% in Q3 2022 to a low of 60.71% in Q2 2022.
  • Median Net Margin over the past 5 years was 6.18% (2022), compared with a mean of 3.03%.
  • Biggest five-year swings in Net Margin: tumbled -6592bps in 2022 and later soared 6504bps in 2023.
  • Conmed's Net Margin stood at 10.6% in 2022, then fell by -5bps to 10.11% in 2023, then fell by -4bps to 9.76% in 2024, then plummeted by -54bps to 4.49% in 2025, then decreased by -3bps to 4.36% in 2026.
  • The last three reported values for Net Margin were 4.36% (Q1 2026), 4.49% (Q4 2025), and 0.85% (Q3 2025) per Business Quant data.